TABLE 2.
All womena | Nonusers | Users (all methods) | Users (short-acting methods) | Users (long-acting methods) | |
---|---|---|---|---|---|
| |||||
n | 3,929 | 2,719 | 1,210 | 873 | 336 |
Proportion of sample | 69.2 | 30.8 | 22.2 | 8.6 | |
Informed choice (%) | |||||
Knows how to use a method from each group | 38.8 | 35.8 | 45.5 | 39.2 | 62.1 |
Knows an advantage of family planning | 86.1 | 81.7 | 95.9 | 95.2 | 97.8 |
Knows a disadvantage of family planning | 43.0 | 41.0 | 47.4 | 49.1 | 42.8 |
Knows an advantage of her method | · | · | 83.1 | 81.8 | 86.5 |
Knows a disadvantage of her method | · | · | 47.7 | 51.1 | 38.9 |
Knows what to do in case of side effects | · | · | 48.4 | 37.7 | 76.0 |
Told about method removal/permanence | · | · | · | · | 88.8 |
Overall informed choice | 12.1 | 14.7 | 6.0 | 4.9 | 9.0 |
Full choice (%) | |||||
Method from each group is available to her | 69.6 | 69.7 | 69.2 | 70.2 | 66.5 |
Method from each group is affordable to her | 58.8 | 58.1 | 60.3 | 52.4 | 80.8 |
Could get method removed if she wanted | · | · | · | · | 83.5 |
Could afford to get method removed if she wanted | · | · | · | · | 84.0 |
Overall full choice | 55.2 | 57.3 | 50.3 | 52.0 | 45.9 |
Free choice (%) | |||||
nb | 3,600 | 2,390 | 1,210 | 873 | 336 |
Made the choice to use/not use voluntarily | 95.0 | 94.0 | 97.0 | 95.8 | 100 |
Not offered incentives to use/not use method | 100 | 100 | 100 | 100 | 100 |
Did not feel pressured to use method | · | · | 99.7 | 99.6 | 100 |
Felt she could refuse method | · | · | 96.6 | 96.0 | 98.1 |
Is not currently using method against her will | · | · | 98.1 | 98.1 | 98.1 |
Has not been refused discontinuation | · | · | · | · | 97.1 |
Overall free choice | 94.4 | 94.0 | 95.3 | 95.3 | 95.4 |
Contraceptive autonomy (%) | |||||
nb | 3,600 | 2,390 | 1,210 | 873 | 336 |
8.1 | 9.6 | 4.7 | 3.9 | 6.7 |
The contraceptive autonomy indicator is designed such that some subdomains of informed, full, and free choice apply only to some women (i.e., contraceptive users or LARC users). In the “All women” column, data are only presented for subdomains that apply to all women. The overall informed, full, and free choice calculation for all women is calculated by applying the applicable subdomains to one womans contraceptive autonomy score, and presents the proportion of all women who have a given component of contraceptive autonomy or contraceptive autonomy overall.
Data were missing on voluntariness of family planning nonuse for 329 participants. Free choice and full contraceptive autonomy are calculated excluding these participants.